Search research articles
Contact Us
Filters
Showing results (11-20 of 32) with videos related to
Page
of 4
Sort By:
Open Forum Infectious Diseases
|
July 15, 2021
Cefiderocol Activity Against Clinical <i>Pseudomonas aeruginosa</i> Isolates Exhibiting Ceftolozane-Tazobactam Resistance
Patricia J Simner, Stephan Beisken, Yehudit Bergman, et al.
Microbiology Spectrum
|
November 9, 2022
Core Genome Multilocus Sequence Typing and Antibiotic Susceptibility Prediction from Whole-Genome Sequence Data of Multidrug-Resistant Pseudomonas aeruginosa Isolates
Scott A Cunningham, Allison R Eberly, Stephan Beisken, et al.
Open Forum Infectious Diseases
|
July 7, 2023
An NDM-Producing <i>Escherichia coli</i> Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another Step Toward Pan-β-Lactam Resistance
Patricia J Simner, Yehudit Bergman, Rick Conzemius, et al.
Antimicrobial Agents and Chemotherapy
|
August 23, 2021
Core Genome Multilocus Sequence Typing and Prediction of Antimicrobial Susceptibility Using Whole-Genome Sequences of Escherichia coli Bloodstream Infection Isolates
Ritu Banerjee, Scott A Cunningham, Stephan Beisken, et al.
Frontiers in Microbiology
|
August 29, 2019
Clinical Resistome Screening of 1,110 <i>Escherichia coli</i> Isolates Efficiently Recovers Diagnostically Relevant Antibiotic Resistance Biomarkers and Potential Novel Resistance Mechanisms
Carsten Volz, Jonas Ramoni, Stephan Beisken, et al.
Journal of Clinical Microbiology
|
April 17, 2020
Species Identification and Antibiotic Resistance Prediction by Analysis of Whole-Genome Sequence Data by Use of ARESdb: an Analysis of Isolates from the Unyvero Lower Respiratory Tract Infection Trial
Ines Ferreira, Stephan Beisken, Lukas Lueftinger, et al.
Frontiers in Microbiology
|
August 25, 2022
Automated antimicrobial susceptibility testing and antimicrobial resistance genotyping using Illumina and Oxford Nanopore Technologies sequencing data among <i>Enterobacteriaceae</i>
Rick Conzemius, Yehudit Bergman, Peter Májek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 4, 2020
Modifiable Risk Factors for the Emergence of Ceftolozane-tazobactam Resistance
Pranita D Tamma, Stephan Beisken, Yehudit Bergman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 7, 2021
Progressive Development of Cefiderocol Resistance in Escherichia coli During Therapy is Associated With an Increase in blaNDM-5 Copy Number and Gene Expression
Patricia J Simner, Heba H Mostafa, Yehudit Bergman, et al.
Jac-Antimicrobial Resistance
|
May 9, 2022
Combination of phage therapy and cefiderocol to successfully treat <i>Pseudomonas aeruginosa</i> cranial osteomyelitis
Patricia J Simner, Jerald Cherian, Gina A Suh, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 32) with videos related to
Sort By:
Page
of 4
Open Forum Infectious Diseases
|
July 15, 2021
Cefiderocol Activity Against Clinical <i>Pseudomonas aeruginosa</i> Isolates Exhibiting Ceftolozane-Tazobactam Resistance
Patricia J Simner, Stephan Beisken, Yehudit Bergman, et al.
Microbiology Spectrum
|
November 9, 2022
Core Genome Multilocus Sequence Typing and Antibiotic Susceptibility Prediction from Whole-Genome Sequence Data of Multidrug-Resistant Pseudomonas aeruginosa Isolates
Scott A Cunningham, Allison R Eberly, Stephan Beisken, et al.
Open Forum Infectious Diseases
|
July 7, 2023
An NDM-Producing <i>Escherichia coli</i> Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another Step Toward Pan-β-Lactam Resistance
Patricia J Simner, Yehudit Bergman, Rick Conzemius, et al.
Antimicrobial Agents and Chemotherapy
|
August 23, 2021
Core Genome Multilocus Sequence Typing and Prediction of Antimicrobial Susceptibility Using Whole-Genome Sequences of Escherichia coli Bloodstream Infection Isolates
Ritu Banerjee, Scott A Cunningham, Stephan Beisken, et al.
Frontiers in Microbiology
|
August 29, 2019
Clinical Resistome Screening of 1,110 <i>Escherichia coli</i> Isolates Efficiently Recovers Diagnostically Relevant Antibiotic Resistance Biomarkers and Potential Novel Resistance Mechanisms
Carsten Volz, Jonas Ramoni, Stephan Beisken, et al.
Journal of Clinical Microbiology
|
April 17, 2020
Species Identification and Antibiotic Resistance Prediction by Analysis of Whole-Genome Sequence Data by Use of ARESdb: an Analysis of Isolates from the Unyvero Lower Respiratory Tract Infection Trial
Ines Ferreira, Stephan Beisken, Lukas Lueftinger, et al.
Frontiers in Microbiology
|
August 25, 2022
Automated antimicrobial susceptibility testing and antimicrobial resistance genotyping using Illumina and Oxford Nanopore Technologies sequencing data among <i>Enterobacteriaceae</i>
Rick Conzemius, Yehudit Bergman, Peter Májek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 4, 2020
Modifiable Risk Factors for the Emergence of Ceftolozane-tazobactam Resistance
Pranita D Tamma, Stephan Beisken, Yehudit Bergman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 7, 2021
Progressive Development of Cefiderocol Resistance in Escherichia coli During Therapy is Associated With an Increase in blaNDM-5 Copy Number and Gene Expression
Patricia J Simner, Heba H Mostafa, Yehudit Bergman, et al.
Jac-Antimicrobial Resistance
|
May 9, 2022
Combination of phage therapy and cefiderocol to successfully treat <i>Pseudomonas aeruginosa</i> cranial osteomyelitis
Patricia J Simner, Jerald Cherian, Gina A Suh, et al.
Page
of 4